"Kliininen lääketutkimus"

During the past decade, CRST Helsinki Oy conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CRST Helsinki Oy" are "Healthy Volunteers" (2 trials). Many other conditions were trialed in "CRST Helsinki Oy" in a lesser frequency.

Most popular intervention types in "CRST Helsinki Oy" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Indacaterol maleate and glycopyrronium bromide" (1 trials), "Indacaterol/glycopyrronium" (1 trials) and "Ultibro Breezhaler with oral charcoal" (1 trials). Other intervention names were less common.

The vast majority of trials in "CRST Helsinki Oy" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CRST Helsinki Oy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CRST Helsinki Oy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CRST Helsinki Oy, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".